Skip over navigation
Banner
Industry
Directory Facilities Technology Transfer Economic Develop. CT BioHistory (TM)
Career
Job Search Post a Job Destination CT
News/Events
Industry News Submit News Release Calendar Submit Event CEO Reading
Patient
Clinical Trials Drug Development Resources
Education
K-12 Higher Ed BioEd Reading
About
Advertising Feedback Home
 
About
 Advertising
 Feedback
 Home
Quick Links
 Directory
 Job Search
 Facilities
 Calendar
 Advertising
Community Service Ad: CDC Get Vaccinated
Advertising
 
Facilities
 

Earn a UW master’s or certificate in medical engineering or pharmaceutical bioengineering.

ORCA Meeting: Aug. 18 - Provenge® - The Road to Approval


BioHistory Moment: First U.S. patent signed by President George Washington

First U.S. patent signed by President George Washington

On July 31, 1790 Samuel Hopkins was issued the first patent under the new U.S. patent statute signed into law by President Washington on April 10, 1790. The statute created a committee that included the Secretary of State, Secretary of War and Attorney General who were authorized to make a decision on the merit of a properly documented petition. The patent, for a process of making potash, an ingredient used in fertilizer was signed by President George Washington. The original document is in the collections of the Chicago Historical Society.

Hopkins also received the first "Canadian" patent from the Parliament of Lower Canada in 1791, issued "by the Governor General in Council to Angus MacDonnel, a Scottish soldier garrisoned at Quebec City, and to Samuel Hopkins, for processes to make potash and soap from wood ash.

More...

Learn about Seattle's Life Science Incubator Facility

PNDRI Building, First Hill, Seattle, WA. Seattle's Life Science Incubator Research facility was commissioned in 1988, and is a contemporary-designed building provided with modern research systems. Four floors are specifically laboratory space, one floor is a fully equipped vivarium and one floor is clinical space and management offices. The faciility is centrally located in close proximity to downtown Seattle, the University of Washington, the Fred Hutchinson Cancer Research Center, and more.

Learn about this and other biotechnology, medical device and pharmaceutical facilities available for sale, lease or sublease in Connecticut, regionally or nationwide.

More...

(Advertising)


Industry News...

    Free News Release Posting & Archiving Service


  • Chembio Diagnostics reports second quarter 2010 results  Chembio reported revenues were $3.75 million for the three months ended June 30, 2010 versus total revenues of $3.37 million for the three months ended June 30, 2009, and net income of $.62 million for the three months ended June 30, 2010 versus $.11 million for the three months ended June 30, 2009.
    Chembio Diagnostics, Inc.  July 29, 2010  


  • FDA advisory committee recommends approval of Brilinta for acute coronary syndromes  AstraZeneca announced that the FDA Cardiovascular and Renal Drugs Advisory Committee recommended the FDA approve AstraZeneca’s investigational drug ticagrelor for the reduction of thrombotic events in patients with Acute Coronary Syndromes.
    AstraZeneca  July 29, 2010  


  • ArQule announces Initiation by Kyowa Hakko Kirin of phase 2 clinical trial in Asia  ArQule announced the initiation of a Phase 2, single agent trial with ARQ 197 in gastric cancer by Kyowa Hakko Kirin, its exclusive licensee for the development and commercialization of ARQ 197 in the Asian territory consisting of Japan, China (including Hong Kong), South Korea and Taiwan.
    ArQule, Inc.   July 28, 2010  


  • Abbott's SIMCOR(R) receives FDA approval for new dosage strengths  Abbott received FDA approval for two new dosage strengths of SIMCOR(R), a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin – the most commonly prescribed dose of simvastatin – with either 500 mg or 1,000 mg of niacin extended-release.
    Abbott  July 28, 2010  


  • Vertex Pharmaceuticals reports second quarter 2010 financial results  For the quarter ended June 30, 2010, the Company's GAAP net loss was $200.0M, or $1.00 per share, including certain charges totaling $57.5M, compared to a GAAP net loss for the quarter ended June 30, 2009 of $171.3M, or $0.99 per share, including certain charges totaling $42.0M.
    Vertex Pharmaceuticals, Inc.  July 28, 2010  


More... | Submit News Release | Advertising...

EquipNet

New Job Postings...

Free Job Posting Trial Offer
  • Quality Control Supervisor II Bio-Rad Laboratories, Inc. (WA)
  • Drug Safety Physician Seattle Genetics, Inc. (WA)
  • Materials Manager II Bio-Rad Laboratories, Inc. (WA)
  • Postdoctoral Fellow, TCGA Institute for Systems Biology (WA)
  • Postdoctoral Fellow, Computational Immunology Institute for Systems Biology (WA)
More... | Job Advertising... | About Job Postings...
UW Surplus

New Facilities Available...

ATC clean room constructors...validation guaranteed!
  • 890 Embarcadero Road Property -- West Sacramento, CA
  • Icogenex Biotech Incubator -- Seattle, WA
  • Biotech and Life Sciences Incubator -- Seattle, WA
  • University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
  • University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA
More... | Facility Advertising...
Novo Nordisk Banner Ad

Upcoming Events...

  • 08/01/2010: Microscopy & Microanalysis 2010
  • 08/01/2010: Protein Society 24th Annual Symposium
  • 08/03/2010: Social Media and Online Marketing in FDA-Regulated Companies: What You Need to Know to Prepare for Upcoming FDA Guidelines
  • 08/15/2010: NATAS 38th Annual Conference
  • 08/15/2010: 3rd International IUPAC Conference on Green Chemistry
More... | Submit Event | Event Advertising...
Gilead - Careers for Life

Learn About Connecticut's BioHistory

Learn About Connecticut's BioHistory Why is there a life science industry in Connecticut? Is the industry growing? What do other states have?

Through Connecticut BioHistory, you can learn about the scientists, institutions, political leaders, and significant events that have shaped and are still shaping the biotechnology, medical device and life science industry in Connecticut.

More...

BioEvolution Posters

WA BioEvolution 2008 Poster

More More...


July: Juvenile Arthritis Awareness Month

Juvenile Arthritis Awareness Month

The Arthritis Foundation is the only national not-for-profit organization that supports the more than 100 types of arthritis and related conditions.

Celebrating its 60th anniversary this year, the foundation helps people take control of arthritis by providing public health education; pursuing public policy and legislation; and conducting evidence-based programs to improve the quality of life for those living with arthritis.

More...


BioFact

(1911) - The first cancer-causing virus is discovered by Francis Rous.


It's a Small World

  Anthrax Bacteria (Photo Credit: Janice Haney Carr) Anthrax Bacteria (Photo Credit: Janice Haney Carr)  

Science Quote

"Those who are enslaved to their sects are not merely devoid of all sound knowledge, but they will not even stop to learn!"

-  Galen, Claudius, Greek physician, writer
 (c.130-c.200)

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 2010 Info.Resource, Inc. All rights reserved.
Privacy Policy . Terms of Use . Advisory Board . Advertising

ConnecticutLifeScience.com, owned and published by Info.Resource, Inc., is a resource
for the life science industry in the state of Connecticut.